4KHR
HCV NS5B GT1A C316Y with GSK5852
Summary for 4KHR
| Entry DOI | 10.2210/pdb4khr/pdb |
| Related | 4KAI 4KB7 4KBI 4KE5 4KHM |
| Descriptor | NS5B RNA-dependent RNA polymerase, SULFATE ION, [4-({[5-cyclopropyl-2-(4-fluorophenyl)-3-(methylcarbamoyl)-1-benzofuran-6-yl](methylsulfonyl)amino}methyl)-2-fluorophenyl]boronic acid, ... (4 entities in total) |
| Functional Keywords | hcv polymerase, hcv ns5b, site iv inhibitor, boron, p66, p70, rna dependent rna polymerase, rna directed rna polymerase, polymerase, rns dependent rna polymerase, replication-replication inhibitor complex, replication/replication inhibitor |
| Biological source | Hepatitis C virus subtype 1a (HCV) |
| Cellular location | Virion : B1PPP0 |
| Total number of polymer chains | 2 |
| Total formula weight | 129705.76 |
| Authors | Williams, S.P.,Kahler, K.M.,Shotwell, J.B. (deposition date: 2013-05-01, release date: 2013-05-29, Last modification date: 2024-03-13) |
| Primary citation | Maynard, A.,Crosby, R.M.,Ellis, B.,Hamatake, R.,Hong, Z.,Johns, B.A.,Kahler, K.M.,Koble, C.,Leivers, A.,Leivers, M.R.,Mathis, A.,Peat, A.J.,Pouliot, J.J.,Roberts, C.D.,Samano, V.,Schmidt, R.M.,Smith, G.K.,Spaltenstein, A.,Stewart, E.L.,Thommes, P.,Turner, E.M.,Voitenleitner, C.,Walker, J.T.,Waitt, G.,Weatherhead, J.,Weaver, K.,Williams, S.,Wright, L.,Xiong, Z.Z.,Haigh, D.,Shotwell, J.B. Discovery of a Potent Boronic Acid Derived Inhibitor of the HCV RNA-Dependent RNA Polymerase. J.Med.Chem., 57:1902-1913, 2014 Cited by PubMed Abstract: A boronic acid moiety was found to be a critical pharmacophore for enhanced in vitro potency against wild-type hepatitis C replicons and known clinical polymorphic and resistant HCV mutant replicons. The synthesis, optimization, and structure-activity relationships associated with inhibition of HCV replication in a subgenomic replication system for a series of non-nucleoside boron-containing HCV RNA-dependent RNA polymerase (NS5B) inhibitors are described. A summary of the discovery of 3 (GSK5852), a molecule which entered clinical trials in subjects infected with HCV in 2011, is included. PubMed: 23672667DOI: 10.1021/jm400317w PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.45 Å) |
Structure validation
Download full validation report






